Literature DB >> 1115445

Rifampin and warfarin: a drug interaction.

J A Romankiewicz, M Ehrman.   

Abstract

The drug interaction between warfarin and rifampin is not well known. Rifampin has been reported to increase the warfarin requirements in human subjects ingesting these agents simultaneously. The concomitant administration of rifampin and warfarin resulted in the need for an unusually high maintenance dose of warfarin (20 mg per day) in order to produce a therapeutic effect. Withdrawal of rifampin decreased the warfarin requirement by 50%. This effect may be mediated by the ability of rifampin to induce microsomal enzymes and, thus, the catabolism of warfarin. The effect of rifampin on the warfarin requirement of our patient appeared to be maximal 5 to 7 days after the initiation of rifampin and extended a similar length of time after rifampin withdrawal. This interaction appears to be clinically significant.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1115445     DOI: 10.7326/0003-4819-82-2-224

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  12 in total

1.  A case series of the rifampin-warfarin drug interaction: focus on practical warfarin management.

Authors:  Charlotte S Yang; Rosaleen Boswell; Tammy J Bungard
Journal:  Eur J Clin Pharmacol       Date:  2021-01-06       Impact factor: 2.953

2.  Pharmacoepidemiologic Screening of Potential Oral Anticoagulant Drug Interactions Leading to Thromboembolic Events.

Authors:  Meijia Zhou; Charles E Leonard; Colleen M Brensinger; Warren B Bilker; Stephen E Kimmel; Todd E H Hecht; Sean Hennessy
Journal:  Clin Pharmacol Ther       Date:  2020-05-16       Impact factor: 6.875

Review 3.  Pharmacodynamic and pharmacokinetic drug interactions with coumarin anticoagulants.

Authors:  S M MacLeod; E M Sellers
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 4.  Pharmacokinetic drug interactions with rifampicin.

Authors:  K Venkatesan
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

Review 5.  Clinically significant drug interactions with the oral anticoagulants.

Authors:  M D Freedman; A G Olatidoye
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

6.  Rifampin-warfarin interaction in a mitral valve replacement patient receiving rifampin for infective endocarditis: a case report.

Authors:  Amr Mohamed Fahmi; Osama Abdelsamad; Hazem Elewa
Journal:  Springerplus       Date:  2016-01-04

7.  Antithrombotic Dilemmas after Left Atrial Appendage Occlusion Watchman Device Placement.

Authors:  Tania Ahuja; Scarlett Murphy; Daniel J Sartori
Journal:  Case Rep Cardiol       Date:  2019-04-28

Review 8.  Targeting the pregnane X receptor in liver injury.

Authors:  Tao Li; Ruth T Yu; Annette R Atkins; Michael Downes; Robert H Tukey; Ronald M Evans
Journal:  Expert Opin Ther Targets       Date:  2012-08-23       Impact factor: 6.902

Review 9.  Rifampicin-warfarin interaction leading to macroscopic hematuria: a case report and review of the literature.

Authors:  Maria A P Martins; Adriano M M Reis; Mariana F Sales; Vandack Nobre; Daniel D Ribeiro; Manoel O C Rocha; Antônio L P Ribeiro
Journal:  BMC Pharmacol Toxicol       Date:  2013-05-04       Impact factor: 2.483

10.  Describing the profile of patients on concurrent rifampin and warfarin therapy in western Kenya: a case series.

Authors:  M W Maina; S D Pastakia; I Manji; N Kirui; C Kirwa; Rakhi Karwa
Journal:  Drugs R D       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.